We are live on ! Find out more
JAFL

Jay A. Fishman Ltd Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.75%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$825M
AUM Growth
+$42.3M
Cap. Flow
-$52.2M
Cap. Flow %
-6.32%
Top 10 Hldgs %
67.92%
Holding
103
New
10
Increased
17
Reduced
46
Closed
5

Top Buys

Rank Stock Value
1
CMA
Comerica
CMA
+$10.8M
2
MRK icon
Merck
MRK
+$4.9M
3
ZTS icon
Zoetis
ZTS
+$2.56M
4
IEP icon
Icahn Enterprises
IEP
+$2.35M
5
LLY icon
Eli Lilly
LLY
+$1.61M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.5M
2
ABBV icon
AbbVie
ABBV
+$13.7M
3
JPM icon
JPMorgan Chase
JPM
+$6.14M
4
JNJ icon
Johnson & Johnson
JNJ
+$4.88M
5
BX icon
Blackstone
BX
+$3.25M

Sector Composition

Rank Sector Weight
1 Technology 34.33%
2 Financials 14.39%
3 Industrials 12.41%
4 Healthcare 12.15%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
101
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
-4,850
Closed -$237K
J icon
102
Jacobs Solutions
J
$16B
-6,988
Closed -$679K

Similar funds

Jay A. Fishman Ltd's Q2 2023 Portfolio in Review

As of Q2 2023, Jay A. Fishman Ltd held 103 positions worth $825M, up 5.4% from $783M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Jay A. Fishman Ltd withdrew a net $52.2M in Q2 2023, closing 5 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Industrials.

Against the trend, Jay A. Fishman Ltd opened a new position in Comerica worth $11.4M.

  • Jay A. Fishman Ltd's largest Q2 2023 buy was Comerica: 268,325 shares worth $11.4M.
  • Jay A. Fishman Ltd added most to Merck in Q2 2023, an estimated $4.9M increase.
  • Jay A. Fishman Ltd's biggest Q2 2023 reduction was Apple, cutting an estimated $16.5M.
  • Jay A. Fishman Ltd fully exited Bristol-Myers Squibb in Q2 2023, selling an estimated $1.97M.
  • Jay A. Fishman Ltd's ten largest holdings make up 68% of its $825M portfolio in Q2 2023.
  • Jay A. Fishman Ltd opened 10 new positions and closed 5 in Q2 2023.
  • Jay A. Fishman Ltd's portfolio value rose 5.4% quarter-over-quarter to $825M.

Based on Jay A. Fishman Ltd's 13F filing for Q2 2023, filed 15 Aug 2023.